We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
vinod bhuchar
Jan 21, 2022
Combination chemotherapy
SHIVASHANKARA SWAMY M S
Jan 22, 2022
As patient is in visceral crisis and progressed while on endocrine therapy leaves less space for further endocrine therapy with CDK 4/6 inhibitors. Duration of adjuvant hormonal therapy and HR receptor status at progression are also helpful for further discussion. At this point of time I would suggest repeat biopsy and chemotherapy.
Rham Zaki
Jan 23, 2022
Commibination chemotherapy
John Miah
Jan 24, 2022
Cabazitaxel plus fulvestrant and CDK4/6 inhibitor
nedim turan
Jan 24, 2022
Combination chemotherapy
Farid Saleh
Jan 27, 2022
For aspiration of pleural fluid ? ongoing draining
? time between original Dx and metastatic disease ?
>12 months
Could be for CDK4/6 with fulvestrant
sameer chaudhari
Aug 05, 2022
For aspiration of pleural fluid ? ongoing draining
? time between original Dx and metastatic disease ?
>12 months
Could be for CDK4/6 with fulvestrant
mehrdad payadeh
Oct 28, 2022
Oral chemotherapy combined with combination hormone therapy
Apr 16, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Sameer
Nasir
MD
vinod bhuchar
Jan 21, 2022
SHIVASHANKARA SWAMY M S
Jan 22, 2022
Rham Zaki
Jan 23, 2022
John Miah
Jan 24, 2022
nedim turan
Jan 24, 2022
Farid Saleh
Jan 27, 2022
sameer chaudhari
Aug 05, 2022
mehrdad payadeh
Oct 28, 2022
Apr 16, 2024
Pending Moderator approval.